Betula verrucosa for treating moderate to severe allergic rhinitis or conjunctivitis caused by tree pollen

Betula verrucosa (Itulazax 12 SQ‑Bet, Alk‑Abelló) is indicated 'in adults and children (5 years or older) for the treatment of moderate-to-severe allergic rhinitis and/or conjunctivitis induced by pollen from the birch homologous group. Itulazax is indicated in patients with a clinical history of symptoms despite use of symptom-relieving medication and a positive test of sensitisation to a member of the birch homologous group (skin prick test and/or specific IgE)'.

The dosage schedule is available in the summary of product characteristics for betula verrucosa.

The list price of betula verrucosa is £80.12 per pack of 30 tablets (excluding VAT; company submission).

Costs may vary in different settings because of negotiated procurement discounts.

For information, Alk‑Abelló did not disclose its Carbon Reduction Plan for UK carbon emissions.